FDA under pressure to relax drug rules

Heidi Ledford

Nature, 2012, vol. 492, issue 7427, 19-19

Abstract: Industry says antibiotic pipeline is being blocked by overly stringent clinical-trial requirements for new treatments.

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/492019a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:492:y:2012:i:7427:d:10.1038_492019a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/492019a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().